ADLM Clinical Chemistry Journal Features Maternal-Fetal Diagnostics
Special issue explores advances in noninvasive prenatal screening, molecular diagnostics, and care disparities affecting perinatal outcomes.
Category: Prenatal Testing
Prenatal Testing
Latest
Prenatal Testing
Latest
Prenatal Genetic Screening Won’t Lead to ‘Designer Babies’
Gattaca Genomics aims to enhance family-building through advanced prenatal genetic screening, increasing the success rates and access.
Prenatal Testing
Latest
Blood Test Predicts Severe Preeclampsia Earlier, More Accurately
The test can be used between 23 and 35 weeks of pregnancy to predict development of severe preeclampsia among women who have symptoms of, or have been diagnosed with, hypertension during pregnancy.
Biomarker Panel May Help Predict Gestational Diabetes Early in Pregnancy
Researchers may have identified an effective way of detecting gestational diabetes mellitus (GDM) earlier in pregnancy.
Read More
Sera Prognostics’ Data Shows Benefit of Preterm Birth Risk Assessment Tool
Sera Prognostics, a company focused on curbing preterm birth risks, demonstrated data on the health and economic benefits of its PreTRM test.
Read More
FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests
The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of results with NIPS tests.
Read More
Machine Learning Helps Predict Postpartum Hemorrhage Risk
Sema4 and Mount Sinai collaborated on two studies that demonstrate how machine learning can be used to improve postpartum hemorrhage risk prediction.
Read More
New Testing Device Helps Identify Risk for Preterm Birth
Researchers have developed a testing device that may help advance diagnosis and treatment of preterm birth.
Read More
Prenatal Test Developed for At-Risk Pregnancies
Veritas has created a new prenatal diagnostic test that can help identify fetal anomalies in at-risk pregnancies.
Read More
Biomarkers Id’d that May Detect Pregnancy Risks Earlier
Researchers have identified biological markers that could improve blood tests of pregnant women to detect risks of pregnancy complications earlier.
Read More
BioFluidica to Commericalize LiquidScan Biopsy System
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read More
Portfolio of Reproductive Information-Driven Genomic Solutions Introduced
Sema4 Elements, a portfolio of information-driven genomic reproductive health solutions that enable providers to treat patients holistically, has launched.
Read More
Many Pregnant Women Don’t Get Blood Test to Check Iron Levels
Half of pregnant women who had a simple blood test to check their iron stores had low iron levels; one in four had severe iron deficiency.
Read More
BioReference Laboratories Acquires Prenatal Testing Business from Roche
BioReference Laboratories, Inc. has acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche.
Read More
EchelonDx, Cradle Genomics Join Forces on Non-Invasive Prenatal Diagnostic Products
As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read More
Real-World Evidence Shows Cost Effectiveness of Offering NIPT to All Pregnant Women
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Read More
Scientists Develop Blood Test to Predict Environmental Harms to Children
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read More
Sera Prognostics PreTRM Blood Test Gets CPT PLA Code
The new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.
Read More